This talk will cover recent clinical trials presented at the ADA in 2019 that have an impact on the management of diabetes, such as cardiovascular outcomes trials and the first oral GLP-1 RA phase 3 data. The faculty will take you through the latest guidelines from the ADA regarding the management of type 2 diabetes and describe how recent clinical trial data has been integrated in to these guidelines. After this meeting review, you will be equipped to manage type 2 diabetes based on these guidelines.
Anxiety Disorders affect a large portion of our population, are prevalent across cultures and carry a significant degree of disability. I my talk, I will briefly describe the current theoretical models we use to understand anxiety. I will describe in some detail several conditions that fall under the umbrella of anxiety disorders (GAD, social anxiety, and panic disorder) and, in each case, will focus on prevalence, pathogenesis, clinical diagnosis, comorbidities and course. I will finally focus on treatment options, including psychotherapeutic and psychopharmacologic approaches.
Controversies around ADHD continue, and higher rates of patients are diagnosed in the U.S., raising concerns about over-diagnosis and treatment. Physicians are often placed in the middle, with the demands of patients for stimulant medications posing a challenge to good care. Conversely, there is more and more evidence for developmentally-based impairments in attention that can respond well to medication. How can we accurately diagnose and treat ADHD with these countervailing forces? A rational, data-based approach is presented including the benefits and side-effects of different approaches, including behavioral strategies. The differential diagnosis is reviewed and cautions around particular "at-risk" populations will be detailed.
In the third episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss important information for clinicians to relay to their patients regarding COVID-19. They will review current recommendations around how patients should be instructed to protect themselves and high-risk family members, how to monitor symptoms when sick, and how to determine when it’s appropriate to end self-isolation. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 04/16/2020 and they are subject to change as new information is published.
Many families worry about autism, even when their child’s development seems to be on track. Families also wonder about vaccine safety and hesitate to follow the recommended guidelines for vaccine administration. This interactive large-group session is designed to help primary care providers to understand whether there is an increase in autism, how to recognize autism in a primary care setting, where to refer, and how to discuss vaccine safety with families.
Get questions answered by expert faculty in Psychiatry.
This podcast will provide an update on autism spectrum disorder (ASD) including surveillance and screening, clinical signs, evaluation, diagnosis, and management.
Take part in this interactive video-based activity that has been engineered to support your learning! Join neurology and primary care experts as they discuss the diagnosis of migraine and its acute management through a combination of video, quiz-questions, pop-up teaching points, and downloadable resources. Faculty will describe newer classes of acute treatment that have recently been approved for migraine, reviewing their indications, and comparing them with older treatment options. Through this activity, you will have access to a robust resource library, including slides, abstracts, and practice tools selected by the faculty, and which can be downloaded for future reference.
In the sixth episode of Pri-Med’s weekly web series on COVID-19, faculty will interview a patient who recently recovered from COVID-19. This patient will share his experience from diagnosis to recovery, including thoughts on his interaction with the healthcare system during this unique time. This session aims to give clinicians a better understanding of the patient perspective, and helps us recognize where there is potential for improvement in caring for patients with COVID-19. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 05/07/2020 and they are subject to change as new information is published.
In the seventh episode of Pri-Med’s weekly web series on COVID-19, faculty will start off a multi-episode spanning discussion on COVID-19 treatment by analyzing recent evidence of antiviral therapies. They will also review the current recommendations regarding their use in patients with COVID-19. Therapies to be discussed in this episode will include: • Convalescent Plasma • Camostat Mesilate • Lopinavir/Ritonavir • Hydroxychloroquine and Chloroquine • Remdesivir Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 05/14/2020 and they are subject to change as new information is published.
In the ninth episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss ongoing treatment considerations and controversies. They will review the potential role of steroids and vitamins in treating and preventing COVID-19, as well as the safety of commonly used medications including ibuprofen, ARBs, and ACE inhibitors in patients with or at risk for COVID-19. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 5/28/2020 and they are subject to change as new information is published.